Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19,398 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pembrolizumab for the treatment of disease relapse following allogeneic hematopoietic stem cell transplantation.
Godfrey J, Liu H, Yu J, Tallarico M, Curran E, Artz AS, Riedell PA, Stock W, Karrison T, Fitzpatrick C, Venkataraman G, Cooper A, Smith SM, Bishop MR, Kline J. Godfrey J, et al. Among authors: smith sm. Blood Adv. 2022 Aug 16:bloodadvances.2022008403. doi: 10.1182/bloodadvances.2022008403. Online ahead of print. Blood Adv. 2022. PMID: 35973200
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma.
Salles GA, Schuster SJ, Dreyling M, Fischer L, Kuruvilla J, Patten PE, von Tresckow B, Smith SM, Jiménez-Ubieto A, Davis KL, Anjos C, Chu J, Zhang J, Lobetti-Bodoni CL, Thieblemont C, Fowler NH, Dickinson M, Martínez-López J, Wang Y, Link BK. Salles GA, et al. Among authors: smith sm. Blood Adv. 2022 Aug 16:bloodadvances.2022008150. doi: 10.1182/bloodadvances.2022008150. Online ahead of print. Blood Adv. 2022. PMID: 35973192
19,398 results
You have reached the last available page of results. Please see the User Guide for more information.